March 22, 2019asia

thumbnail
China Purchase

PPD to Spin Off, Acquire

October 29, 2009

The contract research organization (CRO) PPD unleashed enough news for a year this week. The company announced a long list of new directions, ominous numbers and strategic shifts, including: • The company's quarterly earnings (not great, but not terrible); • The planned acquisition of the Chinese CRO Excel PharmaStudies, which will make PPD a major player in China; • The intent to spin off its compound-partnering business into a separate publicly traded company in early 2010; • The investment of $100 million ($30 million now, the rest later) in Celtic Therapeutics, an investment fund that focuses on therapeutic product candidates. • A new contract with the FDA to evaluate the agency's Center for Drug Evaluation and Research (CDER) post-market spontaneous adverse event surveillance system. Wow. PPD's executive chairman Fred Eshelman told Wall Street it's all part of a plan with “so many details and moving parts” to establish the company as…more...

thumbnail
Immature Market

China: Not There Yet

August 03, 2009

There is lots of buzz about China being the next hot place for global clinical trials. The numbers being bandied about suggest $2 billion in Chinese pharmaceutical research and development in…more...

thumbnail
Robust Growth

New Parexel Sourcebook

July 20, 2009

There are more active, commercial investigational new drug applications (INDs) circulating through the FDA than ever. Exactly 5,700 at the end of 2008. That's a record high—up 20 percent over the…more...

thumbnail
Friday news briefs

Kendle Earnings Fall

November 02, 2007

Top contract research organization Kendle reported a strong quarter but told Wall Street future profits would be lower than expected. Quarterly revenues jumped 33 percent to $100 million. The company lined…more...

thumbnail
Wednesday News Briefs

CDISC Tech Survey

October 17, 2007

ClinPhone, a leading clinical technology suite, has been granted a Best Technological Development in Clinical Trial Management Systems Award for its drug accountability solution at the inaugural GCPj Awards 2007. The Good Clinical Practice Journal Awards were developed to recognize corporate and individual excellence and celebrate innovation. Bill Byrom, vice president, product management, said: “ClinPhone’s drug accountability…more...

thumbnail
Monday News Briefs

Akamai Web Accelerator

October 15, 2007

CDISC annointed Omnicare Clinical Research registered Registered Solutions Provider status. Said the company’s Mark Penniston, global VP of Biometrics: “Since our first CDISC conformant submission in early 2004, Omnicare Clinical Research has had a rich history of successful data conversions. We recognize the importance of CDISC standards and have invested in providing on-line, up-to-date training for all…more...

thumbnail
Friday News Briefs

Big Wyeth Verdict

October 12, 2007

In Nevada, a jury ordered Wyeth to pay $135 million to three women who took Premarin and Prempro. The jury said Wyeth acted with malice or fraud. Wyeth has no reserve fund for its hormone replacement therapy (HRT) cases, possibly because it has spent tens of billions of dollars to settle fen-phen litigation. The jury apparently was…more...

thumbnail
Covance, Arizona Trial Center

Friday News Briefs

September 28, 2007

Covance expanded its facilities in Singapore for food manufacturers in the region. Manufacturers operating in Asia to export food to the U.S. will soon be able to send samples to a laboratory in Singapore. Chinese state media stated that the Singapore lab will initially focus on the testing of infant formula for release, stability and labeling data,…more...

DSG, Omnicare, ClearTrial

Thursday’s News

Briefs for July 5th.

Plugging Into Asian Opportunities

Culture In Clinical Trials

A leading technology supplier talks about China.

Battery, Connection Glitches

Pfizer e-Diary Case History

A real-world story of an e-diary study in the U.S. and Eastern Europe.

Melbourne Presence

ClinPhone Opens Australian Office

In addition to going public in London this year, the company has recently opened new offices in California and North Carolina, expanded its Chicago operation, and relocated its main U.S. office, in New Jersey, to larger premises.

Emory Investigators

DSG Launches Ecstasia Registry

“The ectasia registry is a giant step forward in addressing one of the most challenging complications of LASIK that we face today,” said Dr. Doyle Stulting, Emory University.

Asian Growth

SAP in China

$150 million to be spent


© 2019 ClinPage. All Rights Reserved.